796 related articles for article (PubMed ID: 18252893)
1. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.
Zhang X; Yeung DC; Karpisek M; Stejskal D; Zhou ZG; Liu F; Wong RL; Chow WS; Tso AW; Lam KS; Xu A
Diabetes; 2008 May; 57(5):1246-53. PubMed ID: 18252893
[TBL] [Abstract][Full Text] [Related]
2. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH).
Urraza-Robledo AI; Giralt M; González-Galarza FF; Villarroya F; Miranda Pérez AA; Ruiz Flores P; Gutiérrez Pérez ME; Domingo P; López-Márquez FC
PLoS One; 2021; 16(5):e0252144. PubMed ID: 34019585
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
[TBL] [Abstract][Full Text] [Related]
4. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
5. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
[TBL] [Abstract][Full Text] [Related]
6. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.
Tyynismaa H; Raivio T; Hakkarainen A; Ortega-Alonso A; Lundbom N; Kaprio J; Rissanen A; Suomalainen A; Pietiläinen KH
J Clin Endocrinol Metab; 2011 Feb; 96(2):E351-5. PubMed ID: 21123446
[TBL] [Abstract][Full Text] [Related]
7. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
8. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E
Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522
[TBL] [Abstract][Full Text] [Related]
9. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents.
Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT
Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
[TBL] [Abstract][Full Text] [Related]
11. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects.
Jin QR; Bando Y; Miyawaki K; Shikama Y; Kosugi C; Aki N; Funaki M; Noji S
J Med Invest; 2014; 61(1-2):28-34. PubMed ID: 24705745
[TBL] [Abstract][Full Text] [Related]
12. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
13. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
[TBL] [Abstract][Full Text] [Related]
14. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
[TBL] [Abstract][Full Text] [Related]
15. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
[TBL] [Abstract][Full Text] [Related]
16. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
[TBL] [Abstract][Full Text] [Related]
17. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
[TBL] [Abstract][Full Text] [Related]
18. Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.
Ko BJ; Kim SM; Park KH; Park HS; Mantzoros CS
Int J Obes (Lond); 2014 Dec; 38(12):1497-502. PubMed ID: 24638201
[TBL] [Abstract][Full Text] [Related]
19. Sleep Duration and Cardiometabolic Risk Among Chinese School-aged Children: Do Adipokines Play a Mediating Role?
Li L; Fu J; Yu XT; Li G; Xu L; Yin J; Cheng H; Hou D; Zhao X; Gao S; Li W; Li C; Grant SFA; Li M; Xiao Y; Mi J; Li M
Sleep; 2017 May; 40(5):. PubMed ID: 28329079
[TBL] [Abstract][Full Text] [Related]
20. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
